Current status of high dose progestin treatment in advanced breast cancer
- 1 June 1983
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 3 (2), 231-235
- https://doi.org/10.1007/bf01803566
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Randomized Trial Comparing Surgical Adrenalectomy with Aminoglutethimide plus Hydrocortisone in Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Treatment of Advanced Breast Cancer with Progestins: A reviewActa Obstetricia et Gynecologica Scandinavica, 1981
- Medroxyprogesterone Acetate (MPA) Plasma Levels After Oral and Intramuscular Administration in A Long‐Term StudyActa Obstetricia et Gynecologica Scandinavica, 1981
- High-Dose Medroxyprogesterone Acetate (MPA) Treatment in Advanced Breast Cancer. A ReviewTumori Journal, 1979
- High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapyCancer Chemotherapy and Pharmacology, 1979
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- High Dose Medroxyprogesterone Acetate (MPA) Treatment in Metastatic Carcinoma of the Breast: A Dose-Response EvaluationTumori Journal, 1978
- POSSIBLE NEW APPROACH TO TREATMENT OF METASTATIC BREAST-CANCER - MASSIVE DOSES OF MEDROXYPROGESTERONE ACETATE1978
- High Dose Medroxyprogesterone-Acetate Treatment in Advanced Mammary Carcinoma: A Phase II InvestigationActa Radiologica: Oncology, Radiation, Physics, Biology, 1978
- [Use of high doses of medroxyprogesterone acetate in the palliative treatment of advanced breast cancer. Clinical experience with 44 cases].1977